Tag: Burkholderia cepacia

According to one Australian study, the median intensive phase for melioidosis was 26 days, followed by 3–6 months of oral therapy. This exemplifies why there is no single answer to the question, “**how long to treat Burkholderia**?” as the duration is highly dependent on the specific bacterial species, clinical presentation, and patient factors.

While there is no current widespread, active recall on all fluticasone products, multiple specific lots from manufacturers, including Apotex Corp. and Akorn, Inc., have been recalled in recent years due to issues ranging from glass particles to microbial concerns. This history highlights the importance of checking product details for safety alerts, particularly concerning generic versions of fluticasone.

In 2016, a Class II recall was issued for nearly 1,500 cases of Lactulose Solution, USP, by its manufacturer, VistaPharm, Inc.. This action addressed the question of **why was lactulose recalled**, specifically citing microbial contamination. The contamination involved the presence of *Burkholderia cepacia* bacteria in the bulk solution.

In 2009, Procter & Gamble voluntarily recalled specific lots of Vicks Sinex nasal spray after routine testing discovered bacterial contamination. This was the primary incident that led many to question, 'Why was Vicks nasal spray discontinued?' though the product line itself was never permanently ended.